Aurobindo Pharma consolidated net profit rises 25.20% in the June 2026 quarter

Sales rise 16.86% to Rs 9105.82 crore

Net profit of Aurobindo Pharma rose 25.20% to Rs 1032.56 crore in the quarter ended June 2026 as against Rs 824.75 crore during the previous quarter ended June 2025. Sales rose 16.86% to Rs 9105.82 crore in the quarter ended June 2026 as against Rs 7791.77 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	9105.82	7791.77	17
OPM %	20.64	20.57	-
PBDT	2042.09	1612.50	27
PBT	1555.27	1206.80	29
NP	1032.56	824.75	25

Powered by Capital Market - Live News